Biblio Discovery — Demo Discovery Service

5 hasil untuk "Sutar"

Menampilkan 1–5 · 0,57 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity

    Jyoti Sutar; Suprit Deshpande; Ranajoy Mullick dkk.

    PLOS ONE, Vol. 16 No. 5 · 2021 · Inggris · PLOS Scopus

    Evolving diversity in globally circulating HIV-1 subtypes presents a formidable challenge in defining and developing neutralizing antibodies for prevention and treatment. HIV-1 subtype C is responsible for majority of global HIV-1 infections. In the present study, we examined the diversity in…

  2. Artikel Jurnal Teks lengkap

    Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis

    Yogesh Sutar; Sunna Nabeela; Shakti Singh dkk.

    PLOS Biology, Vol. 20 No. 8 · 2022 · Inggris · PLOS Scopus

    Candida albicans biofilms are a complex multilayer community of cells that are resistant to almost all classes of antifungal drugs. The bottommost layers of biofilms experience nutrient limitation where C. albicans cells are required to respire. We previously reported that a protein Ndu1 is…

  3. Artikel Jurnal Teks lengkap

    Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India

    Shubhangi Dhakulkar; Mrinalini Das; Narendra Sutar dkk.

    PLOS ONE, Vol. 16 No. 2 · 2021 · Inggris · PLOS Scopus

    Background: Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adolescents receiving DR-TB treatment. The study aimed to determine the final treatment outcomes, culture conversion rates…

  4. Artikel Jurnal Teks lengkap

    A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

    Nitin Hingankar; Suprit Deshpande; Payel Das dkk.

    PLOS Pathogens, Vol. 18 No. 4 · 2022 · Inggris · PLOS Scopus

    Although efficacious vaccines have significantly reduced the morbidity and mortality of COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet need is exacerbated by the emergence and spread of SARS-CoV-2 variants of…